Angiogenin regulates epithelial-mesenchymal transition of hepatocellular carcinoma through upregulation of HMGA2.
Carcinoma, Hepatocellular
/ metabolism
Cell Line, Tumor
Cell Movement
/ physiology
Cell Proliferation
/ physiology
Down-Regulation
Epithelial-Mesenchymal Transition
HMGA2 Protein
/ metabolism
Humans
Liver Neoplasms
/ metabolism
RNA, Small Interfering
/ administration & dosage
Ribonuclease, Pancreatic
/ biosynthesis
Transfection
Up-Regulation
Journal
Die Pharmazie
ISSN: 0031-7144
Titre abrégé: Pharmazie
Pays: Germany
ID NLM: 9800766
Informations de publication
Date de publication:
01 05 2019
01 05 2019
Historique:
entrez:
22
5
2019
pubmed:
22
5
2019
medline:
27
3
2020
Statut:
ppublish
Résumé
Angiogenin (ANG) is known to alter multiple cell behaviors by directly targeting downstream targets, but its role in hepatocellular carcinoma (HCC) remains to be elucidated. The expression of ANG in HCC cell lines was measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. The effects of ANG expression on cell proliferation, cell migration, and hallmarks of epithelial-mesenchymal transition (EMT) process were also investigated. The relationship between ANG and high mobility group AT-hook 2 (HMGA2) was evaluated. ANG expression was increased in HCC cell lines. Downregulating of ANG inhibits proliferation, migration, and EMT of HCC cells. The direct regulation of ANG on HMGA2 was verified by luciferase activity reporter assay and western blot assay. Furthermore, overexpression of HMGA2 reversed the inhibitory effects of ANG downregulation on HCC cell behaviors. Our results illustrated the mechanism that ANG promote the EMT of HCC through targeting HMGA2.
Identifiants
pubmed: 31109401
doi: 10.1691/ph.2019.8943
doi:
Substances chimiques
HMGA2 Protein
0
HMGA2 protein, human
0
RNA, Small Interfering
0
angiogenin
EC 3.1.27.-
Ribonuclease, Pancreatic
EC 3.1.27.5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM